A Phase 2, randomized, partially blinded, active-controlled study assessing the efficacy and safety of variable anticoagulation reversal using the REG1 system in patients with acute coronary syndromes: results of the RADAR trialThomas J. Povsic, John H. Alexander, Andrzej Rynkiewicz et al.|European Heart Journal|2012Cited by 108
Hospital Length of Stay in Patients with Non-ST-segment Elevation Myocardial InfarctionJohn P. Vavalle, Christopher B. Granger, Renato D. Lópes et al.|The American Journal of Medicine|2012Cited by 48
The REG1 Anticoagulation System: A Novel Actively Controlled Factor Ix Inhibitor Using RNA Aptamer Technology for Treatment of Acute Coronary SyndromeJohn P. Vavalle, Mauricio G. Cohen|Future Cardiology|2012Cited by 47
Use of the REG1 anticoagulation system in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the phase II RADAR-PCI studyThomas J. Povsic, Roxana Mehran, John P. Vavalle et al.|EuroIntervention|2014Cited by 29
The Kinetics of Integrilin Limited by Obesity: A multicenter randomized pharmacokinetic and pharmacodynamic clinical trialJohn P. Vavalle, John H. Alexander, Susanna R. Stevens et al.|American Heart Journal|2011Cited by 5